Verdi Oncology Expands in Texas

We represented Verdi Oncology, Inc. in its opening of Texas operations, including its launch of the Verdi Cancer and Research Center of Texas.

The center, which employs Dr. Jivesh Sharma and Dr. Amy Cripps, will provide high quality medical oncology care and early phase clinical trials to patients in the greater Dallas-Fort Worth market. This marks Verdi’s entry into its fourth market since the company’s inception in 2018, following expansions into Indiana, Michigan and Tennessee.

Verdi Oncology, Inc., headquartered in Nashville, TN, is an oncology practice and clinical research management company focused on partnering with high-quality oncology physicians and practices.

 

You Also May Be Interested In:

  • Representation of Twin River Worldwide Holdings, Inc. (NYSE: TRWH) in its definitive agreement to acquire Jumer’s Casino & Hotel, from Delaware North Companies Gaming & Entertainment, Inc., for $120 million in cash

     

    We represented Twin River Worldwide Holdings, Inc. in its definitive agreement to acquire Jumer's Casino & Hotel, from Delaware North...
    Client Type: Public Company
  • Representation of Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by Shore Capital Partners, in its affiliation with Atlanta Allergy & Asthma, the largest allergy practice in Georgia

    We represented Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by...
    Client Type: Private Company
  • Representation of Truxton Trust, a subsidiary of financial holding company, Truxton Corporation (OTCPK: TRUX), in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in 2030

    We represented Truxton Trust in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in...
    Client Type: Public Company